COMPANY PROFILE // THE 014 REPORT
Co-Diagnostics, Inc.
CODX (Nasdaq)
Assembled from 4 government sources in 0.1 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
- AmberGLEIF: the direct parent is not reported; reporting exception filed with reason NON_PUBLIC.
- Amber8-K Item 3.01 filed: notice of delisting, of a failed continued-listing rule, or of a transfer of listing on 2026-01-13 and 1 more time (last 24 months).
✓ SEC filings✓ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website✗ Lobbying registration
No SAM registration, no IRS return, no state registration, no website, no lobbying registration on record.
Co-Diagnostics, Inc. is an SEC-registered operating company in surgical & medical instruments & apparatus, incorporated in UT, based in Salt Lake City, UT; listed as CODX (Nasdaq).[source] It reported revenue of $622,489 for the fiscal year ended 2025-12-31.[source] It has filed 67 documents with the SEC in the last 12 months; the latest is Form 8-K, filed 2026-11-13.[source] Its largest institutional holders on 13F filings are ARMISTICE CAPITAL, LLC, JANE STREET GROUP, LLC, VANGUARD CAPITAL MANAGEMENT LLC (as of 2026-06-30).[source] Seraphix flags 2 items from these records: 8-K Item 3.01 filed; GLEIF.[source]
- red0
- amber2
- info0
- ARMISTICE CAPITAL, LLC$732K
- JANE STREET GROUP, LLC$277K
- VANGUARD CAPITAL MANAGEMENT LLC$181K
- Private Advisory Group LLC$122K
- MILLENNIUM MANAGEMENT LLC$99K
- SUSQUEHANNA INTERNATIONAL GROUP, LLP$97K
- GEODE CAPITAL MANAGEMENT, LLC$79K
- VANGUARD FIDUCIARY TRUST CO$61K
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Officers and directors (Forms 3, 4, 5)
- Abbott Richard David · President (Officer) · latest Form 4 2025-11-24 · filing · LinkedIn search
- Brown Brian Lee · Chief Financial Officer (Officer) · latest Form 4 2025-11-24 · filing · LinkedIn search
- Egan Dwight H · Chief Executive Officer (Director,Officer) · latest Form 4 2025-11-24 · filing · LinkedIn search
- Durenard Eugene · Director · latest Form 4 2025-11-24 · filing · LinkedIn search
- MURPHY TED · Director · latest Form 4 2025-08-15 · filing · LinkedIn search
- Murphy Edward L. · Director · latest Form 4 2025-11-24 · filing · LinkedIn search
- NELSON JAMES B · Director · latest Form 4 2025-11-24 · filing · LinkedIn search
- SERBIN RICHARD S · Director · latest Form 4 2025-11-24 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0001692415 | source |
| LEI | 549300Z1JPESYWFM1R93 | source |
| EIN | 46-2609396 | source |
| Business address (SEC) | 2401 S FOOTHILL DRIVE, SALT LAKE CITY, UT, 84109 | source |
Does not exist in the records we hold: UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-03-31 · in 131 days · Next 10-K due (period ended 2026-12-31; Non-accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
- 2027-05-15 · in 176 days · Next 10-Q due (period ended 2027-03-31; Non-accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
- 2027-06-20 · in 212 days · LEI next renewal (549300Z1JPESYWFM1R93)
PEERS BY SIC CODE
Industry context
SIC 3841 (surgical & medical instruments & apparatus): 149 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- STRYKER CORP · 101 SEC filings in 12 months · 1 flag · $502.2M federal (possible match)
- ORASURE TECHNOLOGIES INC · 69 SEC filings in 12 months · 2 flags · $480.7M federal (possible match)
- 3M CO · 124 SEC filings in 12 months · $465.5M federal (possible match)
- BOSTON SCIENTIFIC CORP · 110 SEC filings in 12 months · 1 flag · $140.1M federal (possible match)
- CERUS CORP · 71 SEC filings in 12 months · 2 flags · $126.6M federal (possible match)
- BAXTER INTERNATIONAL INC · 84 SEC filings in 12 months · 1 flag · $54.7M federal (possible match)
- Inspire Medical Systems, Inc. · 100 SEC filings in 12 months · 4 flags · $22.3M federal (possible match)
- ACCURAY INC · 103 SEC filings in 12 months · 4 flags · $13.9M federal (possible match)
- NeuroPace Inc · 61 SEC filings in 12 months · $10.3M federal (possible match)
- TELEFLEX INC · 64 SEC filings in 12 months · 1 flag · $9.4M federal (possible match)
- Cytosorbents Corp · 30 SEC filings in 12 months · 4 flags · $5.0M federal (possible match)
- IRADIMED CORP · 70 SEC filings in 12 months · 1 flag · $4.0M federal (possible match)
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-11-13 officer change 8-K items 5.02,5.07,9.01 · SEC EDGAR
- 2026-11-10 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-11-10 filing 8-K items 2.02,7.01,9.01 · SEC EDGAR
- 2026-11-04 filing S-3 · SEC EDGAR
- 2026-10-26 filing Proxy statement · SEC EDGAR
- 2026-10-16 filing PRE 14A · SEC EDGAR
- 2026-10-15 filing 8-K items 5.07 · SEC EDGAR
- 2026-10-15 filing 8-K/A items 1.01,2.03,3.02,9.01 · SEC EDGAR
- 2026-10-13 filing 8-K items 1.01,2.03,3.02,9.01 · SEC EDGAR
- 2026-10-05 filing 8-K items 5.07 · SEC EDGAR
- 2026-09-25 filing 8-K items 5.07 · SEC EDGAR
- 2026-09-21 filing PRE 14A · SEC EDGAR
- 2026-09-16 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-09-16 filing 8-K items 8.01,9.01 · SEC EDGAR
- 2026-09-15 filing 8-K items 8.01 · SEC EDGAR
- 2026-09-04 officer change 8-K items 5.02 · SEC EDGAR
- 2026-09-04 filing DEFA14A · SEC EDGAR
- 2026-09-04 filing 8-K items 5.07 · SEC EDGAR
- 2026-09-01 filing EFFECT · SEC EDGAR
- 2026-08-24 filing S-3 · SEC EDGAR
- 2026-08-13 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-08-13 filing 8-K items 2.02,7.01,9.01 · SEC EDGAR
- 2026-07-31 filing 8-K items 1.01,3.02,9.01 · SEC EDGAR
- 2026-07-27 filing 8-K items 1.01,9.01 · SEC EDGAR
- 2026-07-27 filing 424B5 · SEC EDGAR
- 2026-07-21 filing Proxy statement · SEC EDGAR
- 2026-07-10 filing PRE 14A · SEC EDGAR
- 2026-05-29 filing EFFECT · SEC EDGAR
- 2026-05-28 filing CORRESP · SEC EDGAR
- 2026-05-28 filing S-3 · SEC EDGAR
170 earlier entries
- 2026-05-28 filing UPLOAD
- 2026-05-22 filing DRS
- 2026-05-21 filing 8-K items 1.01,3.02,8.01,9.01
- 2026-05-15 filing EFFECT
- 2026-05-14 filing Quarterly report (10-Q)
- 2026-05-14 filing 8-K items 2.02,7.01,9.01
- 2026-05-13 filing CORRESP
- 2026-05-12 filing S-3
- 2026-04-14 filing UPLOAD
- 2026-04-10 filing DRS
- 2026-03-31 filing Annual report (10-K)
- 2026-03-31 filing 8-K items 2.02,7.01,9.01
- 2026-03-10 filing 8-K items 2.02,8.01
- 2026-01-21 filing S-8
- 2026-01-13 filing 8-K items 3.01
- 2025-12-30 filing 8-K items 3.03,5.03,7.01,9.01
- 2025-12-19 filing 424B5
- 2025-12-05 filing 8-K items 5.07
- 2025-11-24 insider First Form 3/4/5 on record for Murphy Edward L. (Director)
- 2025-11-13 filing Quarterly report (10-Q)
- 2025-11-13 filing 8-K items 2.02,7.01,9.01
- 2025-11-10 filing Proxy statement
- 2025-10-31 filing PRE 14A
- 2025-10-29 filing 8-K items 1.01,8.01,9.01
- 2025-10-28 filing 424B5
- 2025-10-20 filing 8-K items 1.01,1.02,9.01
- 2025-10-20 filing 424B5
- 2025-09-30 filing 8-K items 7.01,9.01
- 2025-09-18 filing 8-K items 1.01,8.01,9.01
- 2025-09-18 filing 424B5
- 2025-09-16 filing 424B5
- 2025-08-14 filing Quarterly report (10-Q)
- 2025-08-14 filing 8-K items 2.02,7.01,9.01
- 2025-07-11 filing 8-K items 8.01
- 2025-05-29 filing 8-K items 5.07
- 2025-05-27 insider First Form 3/4/5 on record for Abbott Richard David (President)
- 2025-05-27 insider First Form 3/4/5 on record for Brown Brian Lee (Chief Financial Officer)
- 2025-05-27 insider First Form 3/4/5 on record for Egan Dwight H (Chief Executive Officer)
- 2025-05-27 insider First Form 3/4/5 on record for Durenard Eugene (Director)
- 2025-05-27 insider First Form 3/4/5 on record for MURPHY TED (Director)
- 2025-05-27 insider First Form 3/4/5 on record for NELSON JAMES B (Director)
- 2025-05-27 insider First Form 3/4/5 on record for SERBIN RICHARD S (Director)
- 2025-05-08 filing Quarterly report (10-Q)
- 2025-05-08 filing 8-K items 2.02,7.01,9.01
- 2025-04-28 filing 8-K items 1.01,8.01,9.01
- 2025-04-14 filing Proxy statement
- 2025-03-27 filing Annual report (10-K)
- 2025-03-27 filing 8-K items 2.02,7.01,9.01
- 2025-02-21 filing 8-K items 8.01,9.01
- 2025-01-10 filing 8-K items 3.01
- 2024-11-08 filing 8-K/A items 5.07
- 2024-11-07 filing Quarterly report (10-Q)
- 2024-11-07 filing 8-K items 2.02,7.01,9.01
- 2024-10-18 filing 424B5
- 2024-08-30 filing 8-K items 5.07
- 2024-08-08 filing Quarterly report (10-Q)
- 2024-08-08 filing 8-K items 2.02,7.01,9.01
- 2024-07-16 filing Proxy statement
- 2024-06-14 filing 8-K items 8.01,9.01
- 2024-05-09 filing Quarterly report (10-Q)
- 2024-05-09 filing 8-K items 2.02,7.01,9.01
- 2024-03-15 officer change 8-K items 5.02,9.01
- 2024-03-14 filing Annual report (10-K)
- 2024-03-14 filing 8-K items 2.02,7.01,9.01
- 2023-11-09 filing Quarterly report (10-Q)
- 2023-11-09 filing 8-K items 2.02,7.01,9.01
- 2023-08-31 filing 8-K items 5.07
- 2023-08-10 filing Quarterly report (10-Q)
- 2023-08-10 filing 8-K items 2.02,7.01,9.01
- 2023-07-20 filing Proxy statement
- 2023-05-16 officer change 8-K items 5.02,9.01
- 2023-05-11 filing Quarterly report (10-Q)
- 2023-05-11 filing 8-K items 2.02,7.01,9.01
- 2023-04-06 filing EFFECT
- 2023-04-05 filing 8-K items 4.01,9.01
- 2023-04-04 filing CORRESP
- 2023-03-22 filing UPLOAD
- 2023-03-16 filing S-3
- 2023-03-16 filing Annual report (10-K)
- 2023-03-16 filing 8-K items 2.02,7.01,9.01
- 2023-01-23 filing S-8
- 2022-11-10 filing Quarterly report (10-Q)
- 2022-11-10 filing 8-K items 2.02,7.01,9.01
- 2022-09-02 filing 8-K items 5.07
- 2022-08-11 filing Quarterly report (10-Q)
- 2022-08-11 filing 8-K items 2.02,7.01,9.01
- 2022-07-20 filing Proxy statement
- 2022-06-16 filing 8-K items 1.01,9.01
- 2022-05-12 filing Quarterly report (10-Q)
- 2022-05-12 filing 8-K items 2.02,7.01,9.01
- 2022-04-01 filing 8-K items 5.03,9.01
- 2022-03-24 filing Annual report (10-K)
- 2022-03-24 filing 8-K items 2.02,7.01,9.01
- 2022-03-15 filing 8-K items 7.01,8.01
- 2022-01-14 filing D
- 2021-12-23 filing 8-K items 1.01,3.02,7.01,9.01
- 2021-11-12 filing Quarterly report (10-Q)
- 2021-11-12 filing 8-K items 2.02,7.01,9.01
- 2021-08-12 filing Quarterly report (10-Q)
- 2021-08-12 filing 8-K items 2.02,7.01,9.01
- 2021-08-05 filing 8-K items 5.07
- 2021-07-09 officer change 8-K items 5.02
- 2021-06-22 filing Proxy statement
- 2021-05-13 filing 8-K items 2.02,7.01,9.01
- 2021-05-13 filing Quarterly report (10-Q)
- 2021-03-26 filing 8-K items 2.02,7.01,9.01
- 2021-03-25 filing Annual report (10-K)
- 2021-02-22 officer change 8-K items 5.02
- 2021-01-06 filing 8-K items 2.02,7.01,9.01
- 2020-12-17 filing 8-K items 5.07
- 2020-11-20 filing S-8 POS
- 2020-11-16 filing Quarterly report (10-Q)
- 2020-11-16 filing 8-K items 2.02,7.01,9.01
- 2020-11-05 filing EFFECT
- 2020-11-03 filing DEFA14A
- 2020-11-03 filing Proxy statement
- 2020-11-03 filing 10-Q/A
- 2020-11-02 filing 8-K items 4.02,7.01,9.01
- 2020-11-02 filing CORRESP
- 2020-10-29 filing UPLOAD
- 2020-10-23 filing S-3
- 2020-08-13 filing Quarterly report (10-Q)
- 2020-05-15 filing 8-K items 2.02,7.01,9.01
- 2020-05-14 filing Quarterly report (10-Q)
- 2020-04-15 filing S-8
- 2020-03-30 filing Annual report (10-K)
- 2020-02-28 filing 424B5
- 2020-02-27 filing 8-K items 1.01,8.01,9.01
- 2020-02-19 filing 8-K items 8.01,9.01
- 2020-02-12 filing 424B5
- 2020-02-11 filing 8-K items 1.01,8.01,9.01
- 2020-01-27 filing 424B5
- 2020-01-27 filing 8-K items 1.01,8.01,9.01
- 2019-11-12 filing Quarterly report (10-Q)
- 2019-09-05 filing 8-K items 5.07
- 2019-08-14 filing Quarterly report (10-Q)
- 2019-08-09 filing Proxy statement
- 2019-07-05 filing 8-K items 3.01
- 2019-06-26 officer change 8-K items 5.02,9.01
- 2019-05-14 filing Quarterly report (10-Q)
- 2019-04-30 officer change 8-K items 5.02
- 2019-04-01 filing Annual report (10-K)
- 2019-02-25 filing 8-K items 8.01,9.01
- 2019-02-05 filing 8-K items 8.01,9.01
- 2019-02-04 filing 8-K items 1.01,3.02,5.03,8.01,9.01
- 2019-02-04 filing 424B5
- 2019-01-25 filing 8-K items 8.01
- 2019-01-03 filing 8-K items 5.03,5.07,9.01
- 2018-12-12 filing Proxy statement
- 2018-11-30 filing PRE 14A
- 2018-11-14 filing Quarterly report (10-Q)
- 2018-11-01 filing 8-K items 3.01,7.01,9.01
- 2018-09-07 filing EFFECT
- 2018-09-05 filing CORRESP
- 2018-08-29 filing UPLOAD
- 2018-08-14 filing S-3
- 2018-08-10 filing Quarterly report (10-Q)
- 2018-08-09 filing 8-K items 1.01,2.03,9.01
- 2018-05-14 filing Quarterly report (10-Q)
- 2018-03-28 filing Annual report (10-K)
- 2017-11-14 filing Quarterly report (10-Q)
- 2017-08-25 filing Quarterly report (10-Q)
- 2017-07-14 filing 424B4
- 2017-07-13 filing 424B4
- 2017-07-13 filing 8-K items 1.01,8.01,9.01
- 2017-07-12 filing CORRESP
- 2017-07-11 filing EFFECT
- 2017-07-11 filing CORRESP
- 2017-07-11 filing CERTNAS
- 2017-07-11 filing 8-A12B
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-11-19 (within 7 days) 8-K filed: Item 3.03 rights of holders modified; Item 5.03 charter or bylaw amendment; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-11-13 (within 30 days) 8-K filed: Item 5.02 officer or director change; Item 5.07 shareholder vote; Item 9.01 exhibits
- 2026-11-10 (within 30 days) 10-Q filed
- 2026-11-10 (within 30 days) 8-K filed: Item 2.02 results of operations; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-11-04 (within 30 days) S-3 filed
- 2026-10-26 (within 30 days) DEF 14A filed
- 2026-10-16 (older) PRE 14A filed
- 2026-10-15 (older) 8-K filed: Item 5.07 shareholder vote
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-20; the colour is also written out in words.
COUNTS FROM THIS PAGERelationships at a glance
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:CODX The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
0 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 1692415 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | CODX / Nasdaq | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| LEI (root of the ownership tree) | 549300Z1JPESYWFM1R93 | id:lei-family: legal entity in this company's GLEIF ownership tree (LEI 549300Z1JPESYWFM1R93) | GLEIF |
| EIN | 462609396 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001692415 | SEC EDGAR / IRS |
| CUSIP | 189763204 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001692415 | SEC EDGAR |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Revenue (fiscal year ended 2025-12-31) | $622,489 | 2025-12-31 | 10-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax | as filed | 2026-11-20 08:52 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | -$46,895,936 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-20 08:52 UTC | Report an error |
| Total assets (at 2025-12-31) | $24,742,585 | 2025-12-31 | 10-K, XBRL Assets | as filed | 2026-11-20 08:52 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $20,628,664 | 2025-12-31 | 10-K, XBRL StockholdersEquity | as filed | 2026-11-20 08:52 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $11,884,607 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-20 08:52 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-19 | SEC EDGAR company profile | as filed | 2026-11-20 08:52 UTC | Report an error |
| SIC industry | 3841 Surgical & Medical Instruments & Apparatus | 2026-11-19 | SEC EDGAR company profile | as filed | 2026-11-20 08:52 UTC | Report an error |
| State of incorporation | UT | 2026-11-19 | SEC EDGAR company profile | as filed | 2026-11-20 08:52 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-19 | SEC EDGAR company profile | as filed | 2026-11-20 08:52 UTC | Report an error |
| Business address | 2401 S FOOTHILL DRIVE, SUITE D, SALT LAKE CITY, UT, 84109 | 2026-11-19 | SEC EDGAR company profile | as filed | 2026-11-20 08:52 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-19 | SEC EDGAR company profile | as filed | 2026-11-20 08:52 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2025-12-31) | -$29,136,927 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-20 08:52 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31) | $700,047 | 2025-12-31 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | as filed | 2026-11-20 08:52 UTC | Report an error |
| Operating lease liabilities (at 2025-12-31) | $1,236,559 | 2025-12-31 | 10-K, XBRL OperatingLeaseLiability | as filed | 2026-11-20 08:52 UTC | Report an error |
| Form D total offering amount (D filed 2022-01-14) | $47,164,187 | 2022-01-14 | D | as filed | 2026-11-20 08:52 UTC | Report an error |
| Form D total amount sold (D filed 2022-01-14) | $46,559,793 | 2022-01-14 | D | as filed | 2026-11-20 08:52 UTC | Report an error |
| Form D industry group | Biotechnology | 2022-01-14 | D | as filed | 2026-11-20 08:52 UTC | Report an error |
| Form D revenue range | $25,000,001 - $100,000,000 | 2022-01-14 | D | as filed | 2026-11-20 08:52 UTC | Report an error |
| Form D date of first sale | 2021-12-31 | 2022-01-14 | D | as filed | 2026-11-20 08:52 UTC | Report an error |
| Plan (pension, plan no. 001) | CO-DIAGNOSTICS, INC. 401(K) PLAN: 152 participants, assets $8,138,051 | 2025-12-31 | DOL EBSA Form 5500 public datasets (dataset) | as filed | 2026-11-20 08:52 UTC | Report an error |
| Plan (welfare, plan no. 501) | CO-DIAGNOSTICS, INC. BENEFIT PLAN: 109 participants | 2025-12-31 | DOL EBSA Form 5500 public datasets (dataset) | as filed | 2026-11-20 08:52 UTC | Report an error |
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-10 · accession 0001493152-26-050963
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Revenue | $282,881 | 3 months ended 2026-09-30 | 10-Q | 2026-11-10 | 0001493152-26-050963 | 2026-11-20 08:52 UTC | Report an error |
| Net income (loss) | -$6,306,408 | 3 months ended 2026-09-30 | 10-Q | 2026-11-10 | 0001493152-26-050963 | 2026-11-20 08:52 UTC | Report an error |
| Cash and cash equivalents | $714,803 | at 2026-09-30 | 10-Q | 2026-11-10 | 0001493152-26-050963 | 2026-11-20 08:52 UTC | Report an error |
| Contract liabilities, current | $2,000 | at 2026-09-30 | 10-Q | 2026-11-10 | 0001493152-26-050963 | 2026-11-20 08:52 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-11-19 Filing 8-K filed: Item 3.03 rights of holders modified; Item 5.03 charter or bylaw amendment; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-11-13 Filing 8-K filed: Item 5.02 officer or director change; Item 5.07 shareholder vote; Item 9.01 exhibits
- 2026-11-10 Filing 10-Q filed
- 2026-11-10 Filing 8-K filed: Item 2.02 results of operations; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-11-04 Filing S-3 filed
- 2026-10-26 Filing DEF 14A filed
- 2026-10-16 Filing PRE 14A filed
- 2026-10-15 Filing 8-K filed: Item 5.07 shareholder vote
- 2026-10-15 Filing 8-K/A filed: Item 1.01 material agreement; Item 2.03 new financial obligation; Item 3.02 unregistered equity sale; Item 9.01 exhibits
- 2026-10-13 Filing 8-K filed: Item 1.01 material agreement; Item 2.03 new financial obligation; Item 3.02 unregistered equity sale; Item 9.01 exhibits
- 2026-10-05 Filing 8-K filed: Item 5.07 shareholder vote
- 2026-09-25 Filing 8-K filed: Item 5.07 shareholder vote
- 2026-09-21 Filing PRE 14A filed
- 2026-09-18 Filing Form 5500 received for plan year ending 2025-12-31 (plan no. 001)
- 2026-09-16 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-09-16 Filing 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-09-15 Filing 8-K filed: Item 8.01 other event
- 2026-09-04 Filing 8-K filed: Item 5.02 officer or director change
- 2026-09-04 Filing DEFA14A filed
- 2026-09-04 Filing 8-K filed: Item 5.07 shareholder vote
- 2026-09-01 Filing EFFECT filed
- 2026-08-24 Filing S-3 filed
- 2026-08-13 Filing 10-Q filed
- 2026-08-13 Filing 8-K filed: Item 2.02 results of operations; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-07-31 Filing 8-K filed: Item 1.01 material agreement; Item 3.02 unregistered equity sale; Item 9.01 exhibits
4 earlier entries
- 2026-07-27 Filing 8-K filed: Item 1.01 material agreement; Item 9.01 exhibits
- 2026-07-27 Filing Form 5500 received for plan year ending 2025-12-31 (plan no. 501)
- 2023-01-01 Record plan effective date: CO-DIAGNOSTICS, INC. BENEFIT PLAN
- 2020-01-01 Record plan effective date: CO-DIAGNOSTICS, INC. 401(K) PLAN
AS FILED · LARGEST HOLDERS10. 13F institutional holders
| Rank | Holder (13F filer) | Value held | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|---|
| 1 | ARMISTICE CAPITAL, LLC | $731,600 | 2026-06-30 | SEC 13F filing | 2026-11-20 08:52 UTC | Report an error |
| 2 | JANE STREET GROUP, LLC | $276,644 | 2026-06-30 | SEC 13F filing | 2026-11-20 08:52 UTC | Report an error |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | $180,653 | 2026-06-30 | SEC 13F filing | 2026-11-20 08:52 UTC | Report an error |
| 4 | Private Advisory Group LLC | $122,100 | 2026-06-30 | SEC 13F filing | 2026-11-20 08:52 UTC | Report an error |
| 5 | MILLENNIUM MANAGEMENT LLC | $99,184 | 2026-06-30 | SEC 13F filing | 2026-11-20 08:52 UTC | Report an error |
| 6 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | $96,841 | 2026-06-30 | SEC 13F filing | 2026-11-20 08:52 UTC | Report an error |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | $79,282 | 2026-06-30 | SEC 13F filing | 2026-11-20 08:52 UTC | Report an error |
| 8 | VANGUARD FIDUCIARY TRUST CO | $61,306 | 2026-06-30 | SEC 13F filing | 2026-11-20 08:52 UTC | Report an error |
| 9 | UBS Group AG | $49,882 | 2026-06-30 | SEC 13F filing | 2026-11-20 08:52 UTC | Report an error |
| 10 | STATE STREET CORP | $45,880 | 2026-06-30 | SEC 13F filing | 2026-11-20 08:52 UTC | Report an error |
13F as filed: the holder's own report of its position value at the quarter end.
GLEIF OWNERSHIP TREE · ID TIER11. Subsidiaries
1 legal entity in the company's GLEIF ownership tree, joined by LEI (an official identifier).
- Co-Diagnostics, Inc. · LEI 549300Z1JPESYWFM1R93 · root
Exhibit 21 subsidiaries: not held yet.
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/1692415.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001692415. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.